Lymph node micrometastases in patients with early gastric cancer: experience with 139 patients

Ann Surg Oncol. 2001 Mar;8(2):170-4. doi: 10.1007/s10434-001-0170-x.

Abstract

Background: Although lymph node metastases in patients with early gastric cancer (EGC) is an important prognostic factor, the prognostic relevance of lymph node micrometastases is still uncertain.

Methods: The authors studied 1488 lymph nodes, which were histologically confirmed as pN0, dissected from 139 patients who were treated for EGC between 1976-1994. Micrometastases were defined as a single or small cluster of neoplastic cells identifiable only by immunohistochemical methods.

Results: Lymph node micrometastases was observed in 24 of the 139 patients (17%). No significant correlation was observed between micrometastases and other clinicopathological characteristics. Analysis of overall survival showed no significant difference between the micrometastases positive and negative groups.

Conclusion: The results of our study show that the presence of lymph node micrometastases in EGC does not have an influence on patient prognosis.

MeSH terms

  • Aged
  • Chi-Square Distribution
  • Confidence Intervals
  • Female
  • Humans
  • Lymph Node Excision / methods
  • Lymph Nodes / pathology*
  • Lymphatic Metastasis
  • Male
  • Neoplasm Invasiveness
  • Neoplasm Staging
  • Prognosis
  • Retrospective Studies
  • Stomach Neoplasms / blood
  • Stomach Neoplasms / pathology*